Suppr超能文献

终末期肾病患者经透析动静脉分流进行右心导管检查

Right Heart Catheterization via Dialysis Arteriovenous Shunts in End-Stage Renal Disease Patients.

作者信息

Hsieh Mu-Yang, Chen Tsung-Yan, Lin Lin, Liao Min-Tsun, Wang Ren-Huei, Kuo Ruei-Cheng, Lai Chao-Lun, Wu Chih-Cheng

机构信息

Cardiovascular Center, National Taiwan University Hospital Hsinchu Branch, Taiwan, National Taiwan University, College of Medicine, Taiwan, No. 25, Lane 442, Sec. 1, Jingguo Rd, Hsinchu City 300, Taiwan.

出版信息

J Invasive Cardiol. 2016 Dec;28(12):480-484. Epub 2016 Sep 15.

Abstract

OBJECTIVES

Right heart catheterization is an important diagnostic tool but carries risks of adverse events. Little is known about the feasibility and safety of using dialysis arteriovenous (AV) shunts. We aim to evaluate the feasibility and safety of using dialysis AV shunts for access in right heart catheterization.

METHODS

Hemodialysis patients who required right heart catheterization were prospectively enrolled. A 7 Fr sheath was inserted and a balloon-tipped pulmonary artery catheter was advanced for right heart catheterization. Patients were followed for 1 month, and technical success, procedure details, and complications were recorded.

RESULTS

Thirteen patients received right heart catheterization via AV shunts. Three patients were evaluated for heart failure, and 10 were examined for pulmonary hypertension. Median patient age was 69 years (interquartile range [IQR], 58-77 years), and median shunt age was 50 months (IQR, 32-75 months). Five shunts were located in the upper arm, 2 were in the right arm, and 5 were native fistulas. All AV shunt punctures were successful on the first attempt. All right heart catheterizations were completed via AV shunts, and the technical success rate was 100%. Median fluoroscopy time was 6.9 minutes. No venous access complications or right heart catheterization-related complications occurred immediately after the procedure or during the 1-month follow-up period.

CONCLUSIONS

AV dialysis shunts can be used for venous access for right heart catheterization with acceptable feasibility and patient tolerability. Further randomized studies are needed to confirm the benefits of this approach compared with other approaches.

摘要

目的

右心导管检查是一种重要的诊断工具,但存在不良事件风险。关于使用透析动静脉(AV)分流管的可行性和安全性知之甚少。我们旨在评估使用透析AV分流管进行右心导管检查通路的可行性和安全性。

方法

前瞻性纳入需要进行右心导管检查的血液透析患者。插入一根7F鞘管,并推进一根带球囊的肺动脉导管进行右心导管检查。对患者进行1个月的随访,记录技术成功率、操作细节和并发症。

结果

13例患者通过AV分流管接受了右心导管检查。3例患者因心力衰竭接受评估,10例患者因肺动脉高压接受检查。患者中位年龄为69岁(四分位间距[IQR],58 - 77岁),分流管中位使用时间为50个月(IQR,32 - 75个月)。5根分流管位于上臂,2根在右臂,5根为自体动静脉内瘘。所有AV分流管穿刺首次尝试均成功。所有右心导管检查均通过AV分流管完成,技术成功率为100%。中位透视时间为6.9分钟。术后即刻及1个月随访期间均未发生静脉通路并发症或与右心导管检查相关的并发症。

结论

AV透析分流管可用于右心导管检查的静脉通路,具有可接受的可行性和患者耐受性。需要进一步的随机研究来证实这种方法与其他方法相比的益处。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验